RSNA 2014 

Abstract Archives of the RSNA, 2014


SSK24-09

Long-term and Progression-free Survival in Colorectal Cancer Liver Metastases after Thermal Ablation Using MR-guided Laser-induced Thermotherapy in 594 Patients: Analysis of Prognostic Factors

Scientific Papers

Presented on December 3, 2014
Presented as part of SSK24: Vascular/Interventional (IR: Liver Ablation)

Participants

Thomas Josef Vogl MD, PhD, Presenter: Nothing to Disclose
Alena Dommermuth BS, Abstract Co-Author: Nothing to Disclose
Britta Heinle, Abstract Co-Author: Nothing to Disclose
Nour-Eldin Abdelrehim Nour-Eldin MD, MSc, Abstract Co-Author: Nothing to Disclose
Thomas Lehnert MD, Abstract Co-Author: Nothing to Disclose
Stefan Zangos MD, Abstract Co-Author: Nothing to Disclose
Wolf-Otto Bechstein, Abstract Co-Author: Nothing to Disclose
Nagy Naguib Naeem Naguib MD, MSc, Abstract Co-Author: Nothing to Disclose

PURPOSE

To evaluate the prognostic factors for long-term survival and progression-free survival (PFS) after treatment of colorectal cancer (CRC) liver metastases with MR-guided laser-induced thermotherapy (LITT).

METHOD AND MATERIALS

We included 594 patients (mean age, 61.2 years) with CRC liver metastases who were treated with LITT. The statistical analysis of long-term survival and PFS were based on the Kaplan-Meier method. The Cox regression model tested different parameters that could be of prognostic value. The tested prognostic factors were the following: sex, age, location of primary tumor, number of metastases, maximum diameter and total volume of metastases and necroses, quotient of total volumes of metastases and necroses, time of appearance of liver metastases and location in the liver, TNM classification of CRC, extrahepatic metastases, and neoadjuvant treatment.

RESULTS

Median survival was 25 months starting from the date of the first LITT. The 1-, 2-, 3-, 4-, and 5-year PFS rates were 51.3%, 35.4%, 30.7%, 25.4%, and 22.3%, respectively. The number of metastases and their maximum diameter were the most important prognostic factors for both long-term survival and PFS. Long-term survival was also highly influenced by the initial involvement of the lymph nodes.

CONCLUSION

For patients treated with LITT for CRC liver metastases, the number and size of metastases, together with the initial lymph node status, are significant prognostic factors for long-term survival.

CLINICAL RELEVANCE/APPLICATION

MR-guided LITT allows an excellent local control of liver metastases in colorectal cancer

Cite This Abstract

Vogl, T, Dommermuth, A, Heinle, B, Nour-Eldin, N, Lehnert, T, Zangos, S, Bechstein, W, Naguib, N, Long-term and Progression-free Survival in Colorectal Cancer Liver Metastases after Thermal Ablation Using MR-guided Laser-induced Thermotherapy in 594 Patients: Analysis of Prognostic Factors.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14006440.html